Paxlovid’s Promise Falls Flat (Not Worth the Price Tag?)
It looks like Big Pharma has done it again. Remember when Paxlovid was rolled out with great fanfare—promising it would be a game-changer for COVID-19 patients? Pfizer executives certainly hoped you were paying attention—especially while they were charging a whopping $1,650 per treatment. But a new study suggests this expensive medication might not be worth...
Potential COVID-19 Treatment Interacts with THIS Popular Drug
Dear Living Well Daily Reader, Have you heard of the new anti-viral drug that is supposed to put a stop to COVID? The drug, called ritonavir-nirmatrelvir (Paxlovid), is all over the news… and people are clamoring to get it when they or a loved one are struggling with a COVID-19 infection. Things have been moving...